Ezra Cohen to Leukoplakia, Oral
This is a "connection" page, showing publications Ezra Cohen has written about Leukoplakia, Oral.
Connection Strength
0.336
-
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. JCI Insight. 2021 09 08; 6(17).
Score: 0.180
-
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol. 2013 Sep; 49(9):970-976.
Score: 0.102
-
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 01 01; 10(1):32-41.
Score: 0.053